JY
OXFD

Jeff Yass’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Jeff Yass’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11,797
Closed -$162K – 11119
2019
Q2 		$162K Buy
+11,797
New +$180K ﹤0.01% 9316
2019
Q1 		– Sell
-10,238
Closed -$131K – 10272
2018
Q4 		$131K Buy
+10,238
New +$155K ﹤0.01% 8074
2017
Q1 		– Sell
-36,308
Closed -$543K – 10405
2016
Q4 		$543K Buy
+36,308
New +$510K ﹤0.01% 6808

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 42.58% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Jeff Yass's OXFD Position: Q3 2019 in Review

Jeff Yass sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2019, closing a stake of 11,797 shares — an estimated $162K sold.

Jeff Yass first reported a position in OXFD in Q4 2016 and held it in 3 quarters. The position peaked at $543K in Q4 2016. 73 funds tracked by Wall St. Rank hold OXFD as of Q3 2019.

  • Jeff Yass reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2019 after selling out during the quarter.
  • Jeff Yass sold 11,797 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2019, an estimated $162K.
  • Jeff Yass first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 3 quarters.
  • Jeff Yass's Oxford Immunotec Global PLC Ordinary Shares position peaked at $543K in Q4 2016.
  • 73 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2019.

Based on Susquehanna International Group's 13F filing for Q3 2019, filed 14 Nov 2019.